Oklahoma State Board of Pharmacy news, 10/2012

              OK Vol. 25, No. 4 Page 1
4545 N Lincoln Blvd, Suite 112 • Oklahoma City, OK 73105-3413
October 2012
Published to promote compliance of pharmacy and drug law
News
Oklahoma State
Board of Pharmacy
Continued on page 4
Board Welcomes New Board Member
James Spoon, DPh, of Sand
Springs, OK, has been appointed
for a five-year term beginning July
1, 2012 and ending June 30, 2017.
Dr Spoon previously served on the
Oklahoma State Board of Pharmacy
from 2001 to 2011 and replaces
Board member Bill Osborn who
served two consecutive five-year
terms.
Dr Spoon is the owner of several
pharmacies in the Tulsa, OK, area. He is a past president of
the Oklahoma Pharmacists Association, Pharmacy Providers
of Oklahoma, and the Sand Springs Public School System. Dr
Spoon earned his bachelor’s degree in pharmacy from South-western
Oklahoma State University College of Pharmacy and
a doctor of pharmacy degree from the University of Oklahoma
College of Pharmacy.
From the Inspector’s Desk
♦♦ 12.22. Drug Diversion Prevention & Detection Plan: The
Board requires pharmacies and other registrants to have a writ-ten
drug diversion prevention and detection plan. Each plan
should be tailored to your individual needs and be followed.
Hydrocodone and alprazolam are the most highly diverted
and abused drugs in the nation and Oklahoma ranks among
the highest in the nation. Pharmacists should treat these drugs
accordingly. Instead of inventorying them once a year as
required minimally by the law, the Board recommends that
these products be either (1) placed on a perpetual inventory
or (2) audited for their use on a weekly or monthly basis by
comparing purchases and dispensing records against current
inventory to ensure that there is no diversion taking place.
Many times in the past, situations have occurred whereby up
to $10,000 of inventory has been diverted before the pharmacy
became aware that any drugs were missing. It only came to
their attention after the technician was stopped while driving
and several bottles of 500-count hydrocodone or alprazolam
were found in the technician’s car. The Board will be holding
the pharmacy and pharmacists accountable when safeguards
against diversion were not in place. Our profession has been
granted the obligation to safeguard our nation’s drug supply.
We must strive to be one of the solutions to prevent prescrip-tion
drug abuse.
♦♦ 12.23. Theft and Loss Procedures: Any time there is a theft
or loss of controlled substances by a registrant, it must be
reported on Drug Enforcement Administration (DEA) Form
106. Rules require that one copy must be submitted to the
DEA and one copy to the Oklahoma Bureau of Narcotics
and Dangerous Drugs (OBNDD). The Board also requests
that a copy be submitted to the Board of Pharmacy. A link to
the electronic DEA Form 106 may be found on the Board’s
Web site on the “Related Links” page (www.ok.gov/OSBP/
Related_Links/index.html). You will need four copies: one
copy each to the DEA, OBNDD, and Board of Pharmacy, and
one copy for your pharmacy’s records.
♦♦ 12.24. Accurate DEA Numbers: Be sure that you are submit-ting
accurate DEA numbers to the Prescription Monitoring
Program on controlled prescriptions. The Board is still seeing
DEA numbers such as ER5555555. You also must be sure to
submit the correct prescriber. If a mid-level practitioner has
prescribed a controlled substance, then his or her name must
appear on the label and not his or her supervising physician.
The Board is checking for this during its routine inspections.
♦♦ 12.25. Veterinary Issues: The Board has had several com-plaints
recently from veterinarians. If your pharmacy is filling
prescriptions for animals, it is important to understand the
unique needs of veterinarian clients. For example, insulin
for animals is often dosed 40 units per ml and needs U-40
syringes rather than U-100 syringes. These are available from
the veterinarian if your pharmacy is unable to obtain them.
Hydrocodone for dogs cannot be substituted with hydrocodone
w/acetaminophen because acetaminophen is toxic to canines.
Do not make changes to veterinary prescriptions without
contacting the prescriber.
♦♦ 12.26. Tramadol Classified as Schedule IV: Effective No-vember
1, 2012, tramadol and all tramadol-containing products
will be classified as Schedule IV in the state of Oklahoma.
Pharmacies are required to take an inventory of their tramadol
products on November 1, and keep it with their annual con-trolled
dangerous substances (CDS) inventory. Make sure that